We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.82B
AUM Growth
-$235M
Cap. Flow
-$332M
Cap. Flow %
-18.22%
Top 10 Hldgs %
24.45%
Holding
188
New
30
Increased
38
Reduced
74
Closed
46

Top Buys

Rank Stock Value
1
PGNY icon
Progyny
PGNY
+$42.3M
2
LYFT icon
Lyft
LYFT
+$31.7M
3
CNXC icon
Concentrix
CNXC
+$24.7M
4
XRAY icon
Dentsply Sirona
XRAY
+$22.4M
5
GPN icon
Global Payments
GPN
+$21.4M

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$31.5M
2
APTV icon
Aptiv
APTV
+$26.6M
3
ES icon
Eversource Energy
ES
+$22.4M
4
FTDR icon
Frontdoor
FTDR
+$22.4M
5
ETSY icon
Etsy
ETSY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.33%
2 Consumer Discretionary 13.44%
3 Healthcare 11.83%
4 Communication Services 9.64%
5 Consumer Staples 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
176
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
-250,000
Closed -$136M
SUI icon
177
Sun Communities
SUI
$14.4B
-100,264
Closed -$12.1M
TRIP icon
178
TripAdvisor
TRIP
$1.26B
-370,742
Closed -$6.6M
TTEC icon
179
TTEC Holdings
TTEC
$113M
-274,835
Closed -$1.62M
UVV icon
180
Universal Corp
UVV
$1.18B
-63,500
Closed -$3.06M
VET icon
181
Vermilion Energy
VET
$1.75B
-900,328
Closed -$9.91M
WHR icon
182
Whirlpool
WHR
$2.75B
-89,844
Closed -$9.18M
XERS icon
183
Xeris Biopharma Holdings
XERS
$1.46B
-592,078
Closed -$1.33M
SEI
184
Solaris Energy Infrastructure
SEI
$3.86B
-404,735
Closed -$3.47M
ATSG
185
DELISTED
Air Transport Services Group
ATSG
-174,072
Closed -$2.41M
NAPA
186
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
-441,931
Closed -$3.14M
NVEI
187
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
-130,478
Closed -$4.22M
SWN
188
DELISTED
Southwestern Energy Company
SWN
-809,668
Closed -$5.45M

Similar funds

Invenomic Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Invenomic Capital Management held 188 positions worth $1.82B, down 11% from $2.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Invenomic Capital Management withdrew a net $332M in Q3 2024, closing 46 positions and reducing 74 holdings. Its most notable exit was Aptiv, an estimated $26.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in Progyny worth $29.5M.

  • Invenomic Capital Management's largest Q3 2024 buy was Progyny: 1,760,706 shares worth $29.5M.
  • Invenomic Capital Management added most to Lyft in Q3 2024, an estimated $31.7M increase.
  • Invenomic Capital Management's biggest Q3 2024 reduction was Illumina, cutting an estimated $31.5M.
  • Invenomic Capital Management fully exited Aptiv in Q3 2024, selling an estimated $26.6M.
  • Invenomic Capital Management's ten largest holdings make up 24% of its $1.82B portfolio in Q3 2024.
  • Invenomic Capital Management opened 30 new positions and closed 46 in Q3 2024.
  • Invenomic Capital Management's portfolio value fell 11% quarter-over-quarter to $1.82B.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.